NURS FPX 4055 Assessment 4 Health Promotion Plan Presentation

Grace J.
January 20, 2025May 3, 2025
BSN, NURS-FPX4055

Student Name

Capella University

NURS-FPX4055 Optimizing Population Health through Community Practice

Prof. Name

Date

Health Promotion Plan Presentation

Good morning. We’re grateful to have all of you here today to participate in this health promotion session. Today’s topic focuses on preventing Human Papillomavirus (HPV) infection among adolescents and young adults, specifically those aged 11 to 26, in Schwenksville, Pennsylvania. This presentation will inform you about HPV, its association with cancer, the advantages of timely vaccination, and ways to communicate effectively about the HPV vaccine with healthcare professionals and family members. Our session is grounded in SMART goals and aligned with the Healthy People 2030 objectives, ensuring a focused and results-driven approach.

Presentation Roadmap

During this session, we will first present important facts about HPV, including how it is transmitted and its connection to various cancers. We’ll then cover the safety and effectiveness of the HPV vaccine, encouraging everyone to consider scheduling their HPV vaccination within the next 30 days. Our goal is also to build your confidence in discussing this vaccine with healthcare providers and loved ones. We will use interactive activities to enhance your learning experience and close with a post-session quiz and survey to assess knowledge and engagement.

Key Information About HPV and Its Link to Cancer

HPV is a widespread virus primarily spread through skin-to-skin contact during sexual activity. In Pennsylvania, only 68.7% of adolescents are fully vaccinated against HPV, with rural areas like Schwenksville showing significantly lower rates at 48.7% (PA.gov, 2025). HPV is a leading cause of several cancers, including cervical, throat, anal, and genital cancers. High-risk strains such as HPV 16 and 18 can persist in the body, often symptom-free, eventually leading to cellular abnormalities and cancer if not prevented or detected early. While most infections clear up on their own, some persist and lead to serious health outcomes. Vaccination and regular screenings are vital to prevent these outcomes.

Benefits of Timely HPV Vaccination

Vaccinating individuals at a young age—ideally around 11 or 12—ensures that the immune system builds a strong and lasting defense before exposure to the virus. This timing makes the vaccine more effective in preventing HPV-related diseases (Hoes et al., 2021). Timely vaccination can help prevent cervical cancer, one of the most common cancers in women worldwide, as well as other cancers like penile, anal, and oropharyngeal cancers (Cheng et al., 2020). It also protects against genital warts, reducing emotional distress and social stigma. Furthermore, early vaccination contributes to herd immunity by decreasing overall virus transmission, thereby protecting individuals who are not vaccinated or have weakened immune systems (Xu et al., 2024).

Strategies for Discussing HPV Vaccination

Discussing HPV vaccination effectively requires credible information and respectful communication. First, it’s important to rely on facts from trustworthy sources like the CDC or WHO. Using data about vaccine safety and effectiveness can correct misconceptions. Second, asking thoughtful questions—such as about the vaccine’s long-term benefits—can open up dialogue (Kassymbekova et al., 2023). Third, addressing myths with factual counterpoints can help overcome resistance. For instance, it is critical to clarify that HPV vaccination prevents disease and does not encourage early sexual behavior.

Developed SMART Goals with the Participants

Earlier in our planning, we identified SMART goals to measure the session’s success. First, we aim for 90% of participants to accurately identify three key facts about HPV and its cancer link, assessed via a quiz. Second, we hope 80% of participants will commit to scheduling the first HPV vaccine dose within 30 days. Third, our goal is for 85% of participants to report increased confidence in discussing the vaccine with healthcare providers and family members. These goals serve to enhance knowledge, empower individuals, and promote proactive health choices.

Session Evaluation on Developed SMART Goals

Our session effectively met two of the three SMART goals. We succeeded in the first goal, with 92.5% of participants correctly identifying at least three HPV-related facts. The third goal was also achieved, with 85% of participants reporting greater confidence in discussing the vaccine. However, only 75% of attendees committed to scheduling the vaccine, slightly below our 80% target. Some adolescents preferred to consult with their families before deciding, and a few expressed discomfort in handling vaccine myths. To improve, future sessions could include time for family discussions and more interactive role-playing to reinforce communication skills.

Session Evaluation on Healthy People 2030 Objectives

This presentation supports the Healthy People 2030 initiative, particularly the goal of increasing HPV vaccination among adolescents. The session promoted awareness, improved vaccine literacy, and encouraged preventive health behavior. Although vaccine commitment fell just short of the 80% target, the session showed significant progress in aligning with national health priorities. Still, addressing lingering vaccine hesitancy and misinformation is crucial. Future sessions should feature more family engagement, myth-busting tools, and follow-up opportunities to strengthen vaccine uptake and trust.

Conclusion

To conclude, this session emphasized the importance of timely HPV vaccination in preventing cancer and protecting public health in Schwenksville. While we celebrated successes in education and confidence building, we also identified key areas for improvement, especially in vaccine commitment. With continued community engagement and evidence-based strategies, we can make stronger progress toward the Healthy People 2030 goals and foster a healthier future for adolescents and young adults.

Summary Table

Key Focus Area	Details	Impact/Outcome
HPV Facts & Risks	HPV is spread through sexual contact and can lead to cervical, anal, genital, and throat cancers. Rural areas like Schwenksville show low vaccination rates (48.7%) (PA.gov, 2025).	Early detection and vaccination are critical to reducing HPV-related cancer cases.
Vaccination Benefits	Timely vaccination at ages 11–12 leads to a stronger immune response and prevents several cancers and genital warts (Hoes et al., 2021; Cheng et al., 2020).	Helps reduce individual risk and community spread, supporting public health goals.
Communication & SMART Goals	Strategies include evidence-based information, informed questions, and myth-busting (Kassymbekova et al., 2023). SMART goals aimed at improving knowledge, commitment, and communication confidence.	Knowledge goals (92.5%) and communication goals (85%) were met; vaccine scheduling fell short (75%). Improved future strategies are recommended.

References

Cheng, L., Wang, Y., & Du, J. (2020). Human papillomavirus vaccines: An updated review. Vaccines, 8(3), 391. https://doi.org/10.3390/vaccines8030391

Hoes, J., Pasmans, H., Schurink-van ’t Klooster, T. M., van der Klis, F. R. M., Donken, R., Berkhof, J., & de Melker, H. E. (2021). Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics, 18(1). https://doi.org/10.1080/21645515.2021.1908059

Huber, J., Mueller, A., Sailer, M., & Regidor, P.-A. (2021). Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women’s Health, 17. https://doi.org/10.1177/17455065211028996

Kassymbekova, K., Abdukhakimova, A., Zhakipbekova, B., & Kurmangaliyev, A. (2023). Communication approaches in vaccination promotion. Health Promotion International, 38(1). https://doi.org/10.1093/heapro/daac112